Evolocumab | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Evolocumab
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Evolocumab

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 3 Listed Suppliers

3 API Suppliers
3 Listed Suppliers

DEVELOPMENTS

78 Drugs in Development

78 Drugs in Development

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers, 1 FDA Orange Book, 4 Europe, 2 Canada, 4 Australia, 1 South Africa

12 FDF Dossiers
1 FDA Orange Book
4 Europe
2 Canada
4 Australia
1 South Africa

DIGITAL CONTENT

74 News #PharmaBuzz

74 News #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 2 Regulatory FDF Prices, 15 Annual Reports

6 US Medicaid Prescriptions
2 Regulatory FDF Prices
15 Annual Reports

MARKET PLACE

2 APIs, 1 FDF Dossiers

2 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 Health Canada Patents

8 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

8 All

01 8Amgen Canada Inc.

filter Patent Reset all filters

8 All

01 22696252

02 22790018

03 22835294

04 22916259

filter Product Reset all filters

8 All

01 8EVOLOCUMAB

filter Dosage Reset all filters

8 All

01 8SOLUTION

filter Exp Date Reset all filters

8 All

01 22027-12-19

02 22028-08-22

03 22032-05-10

04 22033-06-28

Product Main Page

01

Amgen Canada Inc.

Evolocumab

CPHI Shenzhen

Not Confirmed

Amgen Canada Inc.

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-08-22

Date Granted : 2016-06-14

Brand Name : REPATHA

Patent Number : 2696252

Filing Date : 2008-08-22

Strength per Unit : 140mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-08-22

Date Granted : 2016-06-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Amgen Canada Inc.

Evolocumab

Process Development

Not Confirmed

Amgen Canada Inc.

Process Development

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-19

Date Granted : 2015-02-03

Brand Name : REPATHA

Patent Number : 2790018

Filing Date : 2007-12-19

Strength per Unit : 140mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2027-12-19

Date Granted : 2015-02-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Amgen Canada Inc.

Evolocumab

Process Development

Not Confirmed

Amgen Canada Inc.

Process Development

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-08-22

Date Granted : 2016-06-14

Brand Name : REPATHA

Patent Number : 2696252

Filing Date : 2008-08-22

Strength per Unit : 120mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-08-22

Date Granted : 2016-06-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Amgen Canada Inc.

Evolocumab

Process Development

Not Confirmed

Amgen Canada Inc.

Process Development

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-19

Date Granted : 2015-02-03

Brand Name : REPATHA

Patent Number : 2790018

Filing Date : 2007-12-19

Strength per Unit : 120mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2027-12-19

Date Granted : 2015-02-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Amgen Canada Inc.

Evolocumab

Process Development

Not Confirmed

Amgen Canada Inc.

Country

Process Development

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-06-28

Date Granted : 2024-02-20

Brand Name : REPATHA

Patent Number : 2916259

Filing Date : 2013-06-28

Strength per Unit : 140mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2033-06-28

Date Granted : 2024-02-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Amgen Canada Inc.

Evolocumab

Process Development

Not Confirmed

Amgen Canada Inc.

Country

Process Development

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-05-10

Date Granted : 2023-09-19

Brand Name : REPATHA

Patent Number : 2835294

Filing Date : 2012-05-10

Strength per Unit : 140mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2032-05-10

Date Granted : 2023-09-19

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Amgen Canada Inc.

Evolocumab

Process Development

Not Confirmed

Amgen Canada Inc.

Country

Process Development

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-06-28

Date Granted : 2024-02-20

Brand Name : REPATHA

Patent Number : 2916259

Filing Date : 2013-06-28

Strength per Unit : 120mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2033-06-28

Date Granted : 2024-02-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

Amgen Canada Inc.

Evolocumab

Process Development

Not Confirmed

Amgen Canada Inc.

Country

Process Development

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-05-10

Date Granted : 2023-09-19

Brand Name : REPATHA

Patent Number : 2835294

Filing Date : 2012-05-10

Strength per Unit : 120mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2032-05-10

Date Granted : 2023-09-19

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!